The efforts of bioinformatics company deCode Genetics are starting to pay
off. Earlier this year, the Reykjavik-based company struck a deal with the
Icelandic government that gives it exclusive access to citizens’ medical
records. Now researchers at deCode have identified a gene linked to
schizophrenia, the first of its kind to be found, by scanning the genomes of 400
people with the condition and comparing them to 400 unaffected relatives.
Scientists at Swiss drugs giant Roche will now study the gene to try to
understand its role in the disease.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features

Physics
Gravity's strength measured more reliably than ever before
News

Mind
Symptoms of early dementia reversed by bespoke treatment plans
News

Physics
QBox theory may offer glimpse of reality deeper than quantum realm
News

ÎçÒ¹¸£Àû1000¼¯ºÏ
Is stem cell therapy about to transform medicine and reverse ageing?
Comment
Popular articles
Trending New Scientist articles
1
Largest-ever octopus was great white shark of invertebrate predators
2
Symptoms of early dementia reversed by bespoke treatment plans
3
Is stem cell therapy about to transform medicine and reverse ageing?
4
Why your opinion of used electric vehicles is probably wrong
5
QBox theory may offer glimpse of reality deeper than quantum realm
6
How autoimmune conditions can unexpectedly drive mental illness
7
Huge study reveals how Epstein-Barr virus may cause multiple sclerosis
8
Can you slow ageing with your diet? A new book gives it a go
9
Gravity's strength measured more reliably than ever before
10
You can upgrade your immune system, but not in the way you think